Factors Associated With Initial Treatment Choice, Engagement, and Discontinuation for Patients With Opioid Use Disorder

What is it about?

Clinicians have an important role to play in addressing the opioid epidemic by providing evidence-based treatment for patients with opioid use disorder. Patients who initiated treatment for opioid use disorder with FDA-approved pharmacotherapy stayed in treatment longer than those who did not. Longer treatment duration is associated with better outcomes for patients with opioid use disorder.

Featured Image